Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

60.4K
Overview
60.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

4.5K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

7.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
Necrosis01:16

Necrosis

5.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.8K
Overview of Cell Death01:30

Overview of Cell Death

8.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A discrete time simulation model for kidney allocation in Germany.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

In reply: epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany.

Research and practice in thrombosis and haemostasis·2026
Same author

APOSCREEN-1 - a prospective, single-arm clinical trial for the implementation of a pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-Holstein.

BMC nephrology·2026
Same author

Peritoneal dialysis-induced senescence contributes to treatment failure in long-term PD.

Scientific reports·2026
Same author

Epidemiology, therapy, and outcome of immune-mediated thrombotic thrombocytopenic purpura at population level in Germany.

Research and practice in thrombosis and haemostasis·2026
Same author

Decreasing admissions in older and increasing mortality in younger patients: a nationwide observational study of all German ICU cases 2011-2022.

Critical care (London, England)·2026

Related Experiment Video

Updated: Dec 7, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

2.9K

Plasma Membrane Pores Drive Inflammatory Cell Death.

Benedikt Kolbrink1, Theresa Riebeling1, Ulrich Kunzendorf1

  • 1Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, Kiel, Germany.

Frontiers in Cell and Developmental Biology
|September 25, 2020
PubMed
Summary

Necroptosis and pyroptosis are inflammatory cell death pathways. MLKL and GSDMD proteins mediate these processes, which are increasingly recognized to interact and influence disease.

Keywords:
GSDMDMLKLnecroinflammationnecroptosispyroptosisregulated cell death

More Related Videos

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

3.6K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.1K

Related Experiment Videos

Last Updated: Dec 7, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

2.9K
Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

3.6K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.1K

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Necroptosis and pyroptosis are regulated inflammatory cell death pathways.
  • These processes are executed by mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD) proteins, respectively.
  • Both pathways involve pore formation, leading to cell death and release of inflammatory mediators.

Purpose of the Study:

  • To provide an overview of MLKL and GSDMD structure, activation, and function.
  • To highlight the interconnectedness of necroptosis and pyroptosis.
  • To discuss the clinical relevance and therapeutic implications of these interactions.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of the molecular mechanisms of MLKL and GSDMD.
  • Synthesis of current knowledge on necroptosis and pyroptosis interplay.

Main Results:

  • MLKL and GSDMD form membrane pores, driving inflammatory cell death.
  • Evidence suggests complex interactions between necroptosis and pyroptosis in various disease models.
  • These cell death pathways are implicated in infections, autoimmune diseases, and organ damage.

Conclusions:

  • Necroptosis and pyroptosis are crucial inflammatory processes with significant roles in health and disease.
  • The crosstalk between these pathways is critical and has therapeutic potential.
  • Understanding these interactions can lead to novel treatment strategies for inflammatory conditions.